Abstract

This study compared the diagnostic accuracy of ultrasound and MRI methods for evaluating pathological changes in the luteal stage of rheumatic diseases. One hundred thirty patients from Iraq were enrolled in a randomized trial from 2023 to 2024. The study used expert-grade ultrasound scanners and MRI machines with a 1.5 Tesla magnetic field. The predictive value, sensitivity, and specificity of ultrasound structures were evaluated using MRI as a reference method. The results showed significant differences in data interpretation, with ultrasound showing no false positives and MRI showing the most common false negatives. Prompt identification and treatment of rheumatoid arthritis (RA) are essential for enhancing clinical results and the quality of life for patients. Nevertheless, the early identification of the condition is difficult because of the vague symptoms and the absence of precise diagnostic examinations. This article explores the potential application of MRI in accurately diagnosing, predicting the course of, and monitoring the long-term treatment of rheumatoid arthritis (RA). MRI is a sensitive, accurate, non-invasive tool for evaluating orbital joints in rheumatology patients, identifying abnormalities early, and preventing structural damage, thereby reducing long-term patient monitoring.